Spectrum Pharmaceuticals, Mundipharma deal

Spectrum granted Mundipharma exclusive commercialization rights in Asia, Australia/New Zealand, Africa, the Middle East and Latin America to non-Hodgkin’s lymphoma (NHL) drug Zevalin ibritumomab tiux...